Sandip P. Patel, MD, GRACE Faculty

Sandip P. Patel, MD, Medical Oncologist, Associate Professor of Medicine
UC San Diego Health, Moores Cancer Center
La Jolla
CA
Specialties
Lung Cancer, Immunotherapy, Precision Medicine

Sandip Patel, MD, is a board-certified medical oncologist who specializes in cancer immunotherapy and early phase clinical trials involving immunotherapy across all types of cancer. Dr. Patel is focused on developing personalized therapies that stimulate a patient’s immune system to attack their specific tumor. He believes in offering these promising immunotherapeutics across all tumor types. 

As an associate professor in the Department of Medicine, Dr. Patel instructs medical students, residents and fellows. His research focuses on developing biomarkers for personalized immunotherapy to better determine which combination of therapies works best for each individual.

Dr. Patel completed a fellowship in medical oncology and hematology at Duke University School of Medicine, Duke Medical Center, and a residency in internal medicine at UC Los Angeles School of Medicine, UCLA Medical Center. He earned his medical degree at Baylor College of Medicine, while performing research at MD Anderson Cancer Center. He is board certified in internal medicine, medical oncology, and hematology.  You can read more about Dr. Patel here.
 

Conflict of Interest

None

This next series of videos from the Q&A sessions includes the following videos:

  • Q&A: What Are the Platform Options for SBRT? 
  • Why Some Patients Remain on TKIs Without Acquiring Resistance?
  • High PD-L1:Wait for Genetic Testing Results Before Treatment?

To watch the complete playlist click here.

In this series of videos from the Q&A sessions, the following videos are available for viewing:

Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This includes a Q&A with the audience, as well as a presentation by a patient advocate, Ivy Elkins.

To watch the complete playlist click here.

Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This includes a Q&A with the audience, as well as a presentation by a patient advocate, Ivy Elkins.

To watch the complete playlist click here.

Forum Discussions

Original post date:

Join us now at https://us02web.zoom.us/s/82170808361

the Q&A begins 11:25 ET!

Last Activity: Sat, 08/12/2023 - 07:47
Original post date:

Hi there -- 

Image
montalcino

I am Denise Brock - the Operations Director for GRACE, the Global Resource for Advancing Cancer Education.  I began working with Jack West in 2009, 1 year after my best friend was

Last Activity: Tue, 07/18/2023 - 14:24
Original post date:

There is not a ton of info available for Cholangiocarcinoma, so seeing information come up with new developments is always exciting.  In this video, Rachna Shroff MD, chief of Gastrointestinal Medical

Last Activity: Thu, 10/13/2022 - 17:04
Original post date:

Hi all -- share your cancer journey here and connect with others.  Cancer.gov has a good general description of Cholangiocarcinoma.  This rare disease has support information and programs that can be

Last Activity: Mon, 02/21/2022 - 11:15
Original post date:

Keep your eye out for new Head and Neck information soon! 

Last Activity: Sat, 02/05/2022 - 12:12

Comments

Post Date:
Original Post: Three Year Post Update

Hi Stan!  It is good to hear from you -- I am so very happy you are doing well.  I agree with Janine

Post Date:
Original Post: Two Years After....

Stan - Thank you once again for your kind words.  Thank you as well for your donation.  As you know

Post Date:
Original Post: Jim's caregiver story

I had a very wonderful conversation with a fantastic person, Tom Murphy, after he had started Barb's

Post Date:
Original Post: Denise's Story

Janine -- I know how my world felt, but how is your world different?  - thankfully your husband is

Post Date:

Thank you Janine for mentioning the program!  I wanted to make the point that this program offers a